Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study
Hanne Falk Hansen, Michael Bourke, Trine Stigaard, James Clover, Martin Buckley, Micheal O'Riordain, Des C Winter, Helle Hjorth Johannesen, Rasmus Hvass Hansen, Hanne Heebøll, Patrick Forde, Henrik Loft Jakobsen, Ole Larsen, Jacob Rosenberg, Declan Soden, Julie Gehl, Hanne Falk Hansen, Michael Bourke, Trine Stigaard, James Clover, Martin Buckley, Micheal O'Riordain, Des C Winter, Helle Hjorth Johannesen, Rasmus Hvass Hansen, Hanne Heebøll, Patrick Forde, Henrik Loft Jakobsen, Ole Larsen, Jacob Rosenberg, Declan Soden, Julie Gehl
Abstract
Background and study aims Electrochemotherapy is an anticancer treatment that uses electric pulses to facilitate uptake of chemotherapeutic drugs in tumor cells and has proven to have a high local cytotoxic effect with minimal adverse events. Electrochemotherapy has mostly been used in treatment of cutaneous metastases but development of a new endoscopic electrode device has made treatment of colorectal tumors possible. This first-in-man multicenter phase I study investigated safety and efficacy of electrochemotherapy using endoscopic electroporation in patients with colorectal tumors. Patients and methods Seven patients with colorectal tumors who were deemed ineligible for or had declined standard treatment were included. They were treated with bleomycin either intratumorally or intravenously and the electric pulses were delivered through the endoscopic electrode device. Safety and efficacy were assessed clinically and by scans immediately after treatment and adverse events were reported. Response was evaluated up to 6 months after treatment by scans (magnetic resonance imaging or computed tomography) and endoscopic examinations. Results Seven patients aged 62 to 88 years with multiple comorbidities were included and had one or two treatments each. Post-treatment scans showed tumor responses in the treated areas and no damage to surrounding tissues. Only a few grade one adverse events were reported. Three patients had preoperative rectal bleeding, of which two reported cessation of bleeding and one reported decreased bleeding. Conclusion This first-in-man study shows that electrochemotherapy for colorectal tumors using the endoscopic electrode device can induce local tumor response and is safe also for fragile elderly patients with comorbidities.
Conflict of interest statement
Competing interests Dr. Soden reports a conflict of interest regarding a patent on the EndoVe electrode as well as owner interests in Mirai Medical.
Figures
References
- Torre L A, Bray F, Siegel R L et al.Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.
- Mir L M, Orlowski S. Mechanisms of electrochemotherapy. Adv Drug Deliv Rev. 1999;35:107–118.
- Mir L M. Bases and rationale of the electrochemotherapy. EJC Suppl. 2006;4:38–44.
- Yarmush M L, Golberg A, Sersa G et al.Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng. 2014;16:295–320.
- Gothelf A, Mir L M, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003;29:371–387.
- Orlowski S, Belehradek J, Jr., Paoletti C et al.Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 1988;37:4727–4733.
- Gehl J, Skovsgaard T, Mir L M. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs. 1998;9:319–325.
- Jaroszeski M J, Dang V, Pottinger C et al.Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 2000;11:201–208.
- Marty M, Sersa G, Garbay J R et al.Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006;4:3–13.
- Matthiessen L W, Chalmers R L, Sainsbury D C et al.Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011;50:621–629.
- Matthiessen L W, Johannesen H H, Hendel H W et al.Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial. Acta Oncol. 2012;51:713–721.
- Belehradek M, Domenge C, Luboinski B et al.Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer. 1993;72:3694–3700.
- Campana L G, Mocellin S, Basso M et al.Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol. 2009;16:191–199.
- Curatolo P, Quaglino P, Marenco F et al.Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol. 2012;19:192–198.
- Heller R, Jaroszeski M J, Reintgen D S et al.Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148–157.
- Kis E, Olah J, Ocsai H et al.Electrochemotherapy of cutaneous metastases of melanoma--a case series study and systematic review of the evidence. Dermatol Surg. 2011;37:816–824.
- Quaglino P, Mortera C, Osella-Abate S et al.Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol. 2008;15:2215–2222.
- Clover A JP, Bertino G, Curatolo P Budapest: ESSO38 (European Society of Surgical Oncology, 38th Congress); 2018. Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan- European InspECT Database for 1478 lesions in 691 patients (2008-2018)
- Matthiessen L W, Chalmers R L, Sainsbury D C et al.Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011;50:621–629.
- Benevento R, Santoriello A, Perna G et al.Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report. BMC Surg. 2012;12 01:S6.
- Linnert M, Iversen H K, Gehl J. Multiple brain metastases – current management and perspectives for treatment with electrochemotherapy. Radiol Oncol. 2012;46:271–278.
- Edhemovic I, Gadzijev E M, Brecelj E et al.Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat. 2011;10:475–485.
- Campana L G, Edhemovic I, Soden D et al.Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol. 2019;45:92–102.
- Miklavcic D, Sersa G, Brecelj E et al.Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput. 2012;50:1213–1225.
- Forde P F, Sadadcharam M, Bourke M G et al.Preclinical evaluation of an endoscopic electroporation system. Endoscopy. 2016;48:477–483.
- Oken M M, Creech R H, Tormey D C et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
- Karnofsky D A, Abelmann W H, Craver L F et al.The use of the nitrogen mustards in the palliative treatment of carcinoma – with particular reference to bronchogenic carcinoma. Cancer. 1948;1:634–656.
- Gehl J, Sersa G, Matthiessen L W et al.Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 2018;57:874–882.
- Mir L M, Gehl J, Sersa G et al.Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Suppl. 2006;4:14–25.
- Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One. 2013;8:e59557.
- Sersa G, Cemazar M, Miklavcic D et al.Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res. 1999;19:4017–4022.
- Jarm T, Cemazar M, Miklavcic D et al.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther. 2010;10:729–746.
- Egeland C, Baeksgaard L, Johannesen H H et al.Endoscopic electrochemotherapy for esophageal cancer - a phase I clinical study. Endosc Int Open. 2018;6:E727–E734.
- Falk H, Forde P F, Bay M L et al.Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model. Oncoimmunology. 2017;6:e1301332.
Source: PubMed